Biological markers hs-Troponin T, NT-proBNP and hs-CRP are significant in short-term cardiovascular risk prognosis as well as in treatment decisions, hs-CRP has implications for long-term mortality. Whereas hs-Troponin Tand NT-proBNP had significant prognosis for 30 days to 1 year mortality in patients with non-ST 2 elevation myocardial infarction.